SlideShare a Scribd company logo
1 of 19
Download to read offline
Eden University
UNIT 5 (Diseases of Blood)
Sickle Cell
2,2 Pediatrics Clinical Medicine
Dr. D.Nyirongo MD
UNZA (BSc.HB, MBChB, DTM)
DEFINITIONS
• Sickle Cell Anaemia (SCA) is a homozygous Hemoglobinopathy
characterized by chronic hemolytic anaemia that results from the
inheritance of two mutated β-globin genes coding for hemoglobin S
(Hb SS).
• Sickle Cell Disease (SCD) A heterozygous Hemoglobinopathy
characterized a group of diseases that result from the inheritance of
two mutated β-globin genes, one of which is HbS and the other gene
is either Hb S or other Hb variants such as Hb C, Hb β-thalassemia, Hb
D, and Hb O Arab.
• Sickle cell trait (Hb AS) rarely produces disease and this form protects
against death from endemic Plasmodium falciparum malaria infection
Dr. D. Nyirongo MD 28th July 2023 2
Sickle cell
• NOTE: In sickle cell Anemia, this change encodes valine instead
of glutamine in the 6th position in the β-globin molecule
• In sickle cell anemia, Hb S is commonly as high as 90% of the
total hemoglobin.
• In sickle cell disease, Hb S is >50% of the total hemoglobin.
• The mutant gene is inherited in an autosomal recessive
manner
Dr. D. Nyirongo MD 28th July 2023 3
Inheritance of Sickle Cell Anemia
• If one parent has sickle cell
anaemia (HbSS) and the other
is completely unaffected
(HbAA) then all the children will
have sickle cell trait.
• None will have sickle cell
anemia.
• The parent who has sickle cell
anemia (HbSS) can only pass the
sickle hemoglobin gene to each
of their children.
Dr. D. Nyirongo MD 28th July 2023 4
Inheritance of Sickle Cell Anemia
• If both parents have sickle cell
trait (HbAS) there is a one in four
(25%) chance that any given
child could be born with sickle
cell anemia.
• There is also a one in four chance
that any given child could be
completely unaffected.
• There is a one in two (50%)
chance that any given child will
get the sickle cell trait.
Dr. D. Nyirongo MD 28th July 2023 5
Pathophysiology of anemia in SCA
The major pathophysiologic mechanisms in SCA that cause
the signs, symptoms and complications are:
• Hb S polymerizes in conditions of low oxygen tension
leading to distortion of RBC into a crescent ‘sickle’
shape
• Sickle RBCs are less deformable and obstruct the
microcirculation (vaso-occlusion) resulting in tissue
hypoxia
• Sickle RBC undergo intravascular and extravascular
hemolysis and have a lifespan of only 10-20 days as
compared to 120 days of normal RBCs.
• There is adhesion of sickle RBCs and leukocytes to
activated vascular endothelium leading to
vasoconstriction
Dr. D. Nyirongo MD 28th July 2023 6
Prevalence of symptoms at age
• Six month of age - 6%
• Twelve months of age - 32%
• Two years of age - 61%
• Six years of age - 92%
• eight years of age - 96%
Dr. D. Nyirongo MD 28th July 2023 7
CLINICAL FEATURES
History of
• Swelling and pain of hand and feet i.e.
dactylitis (hand and foot syndrome)
especially in infancy
• Recurrent painful episodes in limbs,
abdomen, back, chest
• In infancy, may present as unexplained
episodes of excessive crying
• Recurrent or persistent jaundice
• Pallor or anaemia that may require
blood transfusions
On examination, may have/be
• small for age
• pallor
• Jaundice
• frontal and parietal bossing
May present in a sickle crises
• Vaso-occlusive crisis (has 5 types)
 Painful crisis
 Dactylitis
 Acute chest syndrome
 Acute CNS event
 Priapism
• Hemolytic crisis
• Sequestration crisis
• Aplastic crisis
Dr. D. Nyirongo MD 28th July 2023 8
SICKLE CELL CRISES
[1] VASO-OCCLUSIVE CRISIS (VOC)
• Vaso-occlusive crises occur due
to disruption of blood flow in
the microvasculature by sickle
cells
• Resulting in tissue ischemia,
temporally loss of function
which may become permanent
and pain
Precipitating Factors for VOC
These include:-
• Infection,
• Dehydration,
• Exposure to cold,
• Emotional and physical stress,
• Hypoxia especially in high
altitude
Dr. D. Nyirongo MD 28th July 2023 9
SICKLE CELL CRISES
Vaso-occlusive crises include The following Types
i. Painful crisis (most common)
ii. Priapism (prolonged, painful erection
of the penis)
iii. Acute chest syndrome
iv. Dactylitis (tender, erythematous and
edematous hands and feet)
v. Stroke (CVA) and
Mnemonic to remember the VOCs= PPADS
NOTE: Discuss how each VOC is Managed?
(iii) ACUTE CHEST SYNDROME
• It is defined a new pulmonary infiltrate on chest
radiograph in the presence of one or more of the
following: fever, tachypnea, dyspnea, hypoxia and
chest pain
• In most cases, there is no identifiable cause, but
in some cases, it may be caused by
Infections – Chlamydia pneumoniae, viral
infections, Mycoplasma pneumoniae
Pulmonary infarctions (from sickled cells)
Fat embolism (from bone marrow infarctions)
Dr. D. Nyirongo MD 28th July 2023 10
SICKLE CELL CRISES
[2] HAEMOLYTIC CRISIS
• >2g/dL drop in Hb from baseline with
reticulocytosis and raised
unconjugated bilirubin
• May result due to painful crises or
infection
• Transfuse with packed cells if Hb fall
to <5g/dL
[3] SEQUESTRATION CRISIS
• It is the sudden enlargement of the
spleen along with > 2 g/dL decrease in
Hb from baseline with reticulocytosis.
• This is an emergency! Because It
occurs rapidly and can result in sudden
circulatory collapse
• It is a common cause of death in
infancy
Clinical Presentation
• Severe pallor with acutely enlarged
spleen
• Hypovolemic shock
• Severe anaemia, thrombocytopenia
and normal reticulocyte count
Dr. D. Nyirongo MD 28th July 2023 11
[4] APLASTIC CRISIS
This is a Transient red cell aplasia commonly caused by parvovirus B19
• Parvovirus B19 has a predilection for young erythroblasts in bone marrow
which are plentiful in hemolytic anemias
• Infection limits the production of reticulocytes
• Infection usually is self-limited
• May present with fever, upper respiratory tract symptoms, fatigue, pallor.
• >2g/dL drop in Hb from baseline, leukopenia with reticulocytopenia.
• The reticulocytopenia may last 7 to 10 days
Dr. D. Nyirongo MD 28th July 2023 12
Long term Complications
• Functional asplenia due to
autosplenectomy
• Increased risk of serious bacterial
infections
• Faltering growth
• Osteomyelitis
• CNS conditions
• Strokes or TIA, convulsions, sensory
hearing loss
• Priapism
• Delayed sexual maturation
• Cholelithiasis
• Renal disease (Gross hematuria,
papillary necrosis, nephrotic syndrome,
renal infarction, hyposthenuria,
pyelonephritis, renal medullary
carcinoma)
• Chronic lung disease (pulmonary
hypertension)
• Congestive heart failure
• Proliferative retinopathy
• Leg ulcers
• Avascular necrosis of the femoral or
humeral heads
• Chronic pain syndrome
Dr. D. Nyirongo MD 28th July 2023 13
Management (Investigations)
1. Clinical
2. Laboratory
• FBC
• Peripheral Blood Smear reviews Sickle cells,
target cells, Howell-jolly bodies
• Reticulocyte count
• X-ray of the skull (hair on endplate
appearance. Frontal bossing)
• Sickling test, solubility test and sickle scan
All three are screening tests, they do not
distinguish between SCD and sickle cell trait
and must be followed up by a more specific
diagnostic tests eg Hb electrophoresis and
HPLC
1. Sickling test – observation of sickled RBCs
on a microscope slide when drops of blood
are exposed to sodium metabisulphite which
causes low oxygen tension
2. Solubility test – observation of turbidity
when drops of blood are mixed with sodium
dithionate in a test tube, insoluble HbS
remains turbid. While HbA which is soluble
in the solution turns clear
3. sickle scan- Detects Hb A, C and S
(quantitatively)
• Hb electrophoresis (measures number,
and type of both normal and abnormal Hb)
• High-performance liquid chromatography
(HPLC) (detects the type of hemoglobin
present)
Dr. D. Nyirongo MD 28th July 2023 14
Management (Treatment)
Mainstay treatment
 Improve Oxygenation and fluids (1.5 times maintenance fluid)
 Pain management (paracetamol->NSAID->Morphine=0.3mg/Kg 4
hourly) NEVER give fentanyl due to risk of seizures
 Vaccinate against encapsulated organisms
8 General treatment Principles
1. Folic acid
2. Malaria prophylaxis
3. Antibiotics
4. Avoid crisis precipitants
5. Regular hospital review
6. Counseling
7. Hydroxyurea
8. Blood Transfusion
(1) Folic acid 5mg daily
(2) Malaria prophylaxis with
Deltaprim (pyrimethamine and dapsone)
• <12kg 50mg once weekly PO
• >12kg, 100mg once weekly PO
Side effect: It can cause agranulocytosis
(3) Antibiotics (Oral penicillin daily)
• because of increased risk of bacterial infections
• Penicillin V until the age of 5 years
2 to 12 months 62.5mg BD
1 to 3 years 125mg BD, then
3 to 5 years 250mg BD. If allergic to pen V, give
erythromycin.
Dr. D. Nyirongo MD 28th July 2023 15
Management (Treatment)
(4) Avoid crisis precipitants
• Precipitants are dehydration, cold, fever, hypoxia
• Advice as follows: hydrate enough, keep warm,
cool when hot, adequate ventilation
• when fever present to go to the clinic/hospital
quickly and not self-treat at home
(5) Regular hospital review
• Frequency of review is based on how patient is
doing
• Monthly reviews in infancy, 2-3 months in older
children or longer if stable
(6) Counseling
• Teach caregivers and patients about the
disease, role of medicines prescribed and
how to avoid VOC precipitants
• Teach caregivers of SCD children aged <3
years how to palpate for the spleen. After
teaching, observe them palpate to ensure
they do it correctly
• Advise to palpate every day when bathing the
child
• Advice to go to the hospital (not clinic) quickly
if spleen is noted
Dr. D. Nyirongo MD 28th July 2023 16
Management (Treatment)
(7) Hydroxyurea
• Mechanisms of action (MOA)
Increases the production of fetal Hb (HbF).
Decrease red cell endothelial adhesion
Increase RBC water content making it
flexible and difficult to polymerize
Cause Nitric oxide release Vasodilatation
Decreases Neutrophil count
• o Indicated in stroke, recurrent painful VOC,
acute chest syndrome
• Dose is 10-15mg/kg once daily initially,
then increase every 12 weeks in steps of
2.5-5mg/kg ,max 35mg/kg daily)
(8) Blood transfusion
This is indicated in:-
• Severe anaemia, sequestration crisis, aplastic crisis,
acute chest syndrome, priapism, stroke
• Do not tansfuse to an Hb to >10g/dL to prevent
hyperviscosity which decreases oxygen delivery
Give packed cells: transfuse 11 times for 6 Months.
1st Month weekly=4 times
2nd & 3rd Month 2 weekly=4 times
Remaining 3 Months Once Monthly=3 times
Amount of Blood=(BW x Hb deficiency) x K
Where K=4 for packed cells
K=6 for whole blood
Dr. D. Nyirongo MD 28th July 2023 17
Transfusion therapy (Indications)
• Vaso-occlusive crisis
 Painful crisis
 Dactylitis
 Acute chest syndrome
 CVA (TCD ultrasound results of more than
200cm/s) or stroke
 Priapism
• Hemolytic crisis
• Sequestration crisis
• Aplastic crisis
• Perioperative
NOTE: Do not raise Hb > 10g/dL
Transfusion complications
• Alloimmunization
• Iron overload
• Infection
Dr. D. Nyirongo MD 28th July 2023 18
Causes of death
• Infection - 48%
• Stroke - 10%
• Complications of therapy - 7 %
• Splenic sequestration - 7 %
• Thromboembolism - 5%
• Renal failure - 4 %
• Pulmonary hypertension - 3 %
Dr. D. Nyirongo MD 28th July 2023 19

More Related Content

Similar to Unit 5 Sickle cell-3.pdf

SICKELE CELL DISEASE MODULE 3 SEJOJO.pptx TO BE PRESENTED. IN TRAININGS.pptx
SICKELE CELL DISEASE   MODULE 3 SEJOJO.pptx TO BE PRESENTED. IN TRAININGS.pptxSICKELE CELL DISEASE   MODULE 3 SEJOJO.pptx TO BE PRESENTED. IN TRAININGS.pptx
SICKELE CELL DISEASE MODULE 3 SEJOJO.pptx TO BE PRESENTED. IN TRAININGS.pptxSEJOJO PHAAROE
 
PAIN MANAGEMENT IN SICKLE CELL DISEASE AND CRISIS.pptx
PAIN MANAGEMENT IN SICKLE CELL DISEASE AND CRISIS.pptxPAIN MANAGEMENT IN SICKLE CELL DISEASE AND CRISIS.pptx
PAIN MANAGEMENT IN SICKLE CELL DISEASE AND CRISIS.pptxCampusHub360
 
Presentation about sickle_cell_anemia_
Presentation about sickle_cell_anemia_Presentation about sickle_cell_anemia_
Presentation about sickle_cell_anemia_DiptaChandraPal
 
Haemolytic anemias due to cell membrane defects
Haemolytic anemias due to cell membrane defectsHaemolytic anemias due to cell membrane defects
Haemolytic anemias due to cell membrane defectsQassamAlraee1
 
Blood Transfusion Center by Slidesgo.pptx
Blood Transfusion Center by Slidesgo.pptxBlood Transfusion Center by Slidesgo.pptx
Blood Transfusion Center by Slidesgo.pptxSAAAE
 
Sickle cell diseases & Beyond.pptx
Sickle cell diseases & Beyond.pptxSickle cell diseases & Beyond.pptx
Sickle cell diseases & Beyond.pptxMudreka3
 
Sickle Cell Anemia.ppt
Sickle Cell Anemia.pptSickle Cell Anemia.ppt
Sickle Cell Anemia.pptfelixkamwanga
 
Sickle cell disease
Sickle cell diseaseSickle cell disease
Sickle cell diseaseYara Mostafa
 
Investigation in dentistry by nabaa.pptx
Investigation in dentistry by nabaa.pptxInvestigation in dentistry by nabaa.pptx
Investigation in dentistry by nabaa.pptxnabaan993
 
Sickle Cell Disease - Obuasi.pptx
Sickle Cell Disease - Obuasi.pptxSickle Cell Disease - Obuasi.pptx
Sickle Cell Disease - Obuasi.pptxYawGyasi2
 
sickel cell anemia
sickel cell anemiasickel cell anemia
sickel cell anemiaodai rjoub
 
Hematology oncology-nurs 3340
Hematology oncology-nurs 3340Hematology oncology-nurs 3340
Hematology oncology-nurs 3340Shepard Joy
 

Similar to Unit 5 Sickle cell-3.pdf (20)

SICKELE CELL DISEASE MODULE 3 SEJOJO.pptx TO BE PRESENTED. IN TRAININGS.pptx
SICKELE CELL DISEASE   MODULE 3 SEJOJO.pptx TO BE PRESENTED. IN TRAININGS.pptxSICKELE CELL DISEASE   MODULE 3 SEJOJO.pptx TO BE PRESENTED. IN TRAININGS.pptx
SICKELE CELL DISEASE MODULE 3 SEJOJO.pptx TO BE PRESENTED. IN TRAININGS.pptx
 
PAIN MANAGEMENT IN SICKLE CELL DISEASE AND CRISIS.pptx
PAIN MANAGEMENT IN SICKLE CELL DISEASE AND CRISIS.pptxPAIN MANAGEMENT IN SICKLE CELL DISEASE AND CRISIS.pptx
PAIN MANAGEMENT IN SICKLE CELL DISEASE AND CRISIS.pptx
 
SICKEL CELL ANEMIA
SICKEL CELL ANEMIA SICKEL CELL ANEMIA
SICKEL CELL ANEMIA
 
Final ppt sickle cell
Final ppt sickle cellFinal ppt sickle cell
Final ppt sickle cell
 
Final ppt sickle cell
Final ppt sickle cellFinal ppt sickle cell
Final ppt sickle cell
 
Presentation about sickle_cell_anemia_
Presentation about sickle_cell_anemia_Presentation about sickle_cell_anemia_
Presentation about sickle_cell_anemia_
 
SCA
SCA SCA
SCA
 
Sickle cell disease
Sickle cell diseaseSickle cell disease
Sickle cell disease
 
Haemolytic anemias due to cell membrane defects
Haemolytic anemias due to cell membrane defectsHaemolytic anemias due to cell membrane defects
Haemolytic anemias due to cell membrane defects
 
Blood Transfusion Center by Slidesgo.pptx
Blood Transfusion Center by Slidesgo.pptxBlood Transfusion Center by Slidesgo.pptx
Blood Transfusion Center by Slidesgo.pptx
 
Sickle cell diseases & Beyond.pptx
Sickle cell diseases & Beyond.pptxSickle cell diseases & Beyond.pptx
Sickle cell diseases & Beyond.pptx
 
Sickle Cell Anemia.ppt
Sickle Cell Anemia.pptSickle Cell Anemia.ppt
Sickle Cell Anemia.ppt
 
Sickle cell disease
Sickle cell diseaseSickle cell disease
Sickle cell disease
 
Investigation in dentistry by nabaa.pptx
Investigation in dentistry by nabaa.pptxInvestigation in dentistry by nabaa.pptx
Investigation in dentistry by nabaa.pptx
 
CLINICAL TEST.pdf
CLINICAL TEST.pdfCLINICAL TEST.pdf
CLINICAL TEST.pdf
 
Sickle Cell Disease - Obuasi.pptx
Sickle Cell Disease - Obuasi.pptxSickle Cell Disease - Obuasi.pptx
Sickle Cell Disease - Obuasi.pptx
 
Anemia
AnemiaAnemia
Anemia
 
sickel cell anemia
sickel cell anemiasickel cell anemia
sickel cell anemia
 
Aplstic anemia
Aplstic  anemiaAplstic  anemia
Aplstic anemia
 
Hematology oncology-nurs 3340
Hematology oncology-nurs 3340Hematology oncology-nurs 3340
Hematology oncology-nurs 3340
 

More from Johnmvula3

Lecture 30. CRICOTHYROIDOTOMY.pptxzbendj
Lecture 30. CRICOTHYROIDOTOMY.pptxzbendjLecture 30. CRICOTHYROIDOTOMY.pptxzbendj
Lecture 30. CRICOTHYROIDOTOMY.pptxzbendjJohnmvula3
 
DISEAShES OF THE EXTERNAL EAR.pdfjdjdjdjdjdjsjssjjssjjsnsns
DISEAShES OF THE EXTERNAL EAR.pdfjdjdjdjdjdjsjssjjssjjsnsnsDISEAShES OF THE EXTERNAL EAR.pdfjdjdjdjdjdjsjssjjssjjsnsns
DISEAShES OF THE EXTERNAL EAR.pdfjdjdjdjdjdjsjssjjssjjsnsnsJohnmvula3
 
HUMAN IMMUNE DEFICIENCY VIRUS AND AIDS.pptx
HUMAN IMMUNE DEFICIENCY VIRUS AND AIDS.pptxHUMAN IMMUNE DEFICIENCY VIRUS AND AIDS.pptx
HUMAN IMMUNE DEFICIENCY VIRUS AND AIDS.pptxJohnmvula3
 
13 - Asthma and COPD.pptxjehehejwehdbsenwjjw
13 - Asthma and COPD.pptxjehehejwehdbsenwjjw13 - Asthma and COPD.pptxjehehejwehdbsenwjjw
13 - Asthma and COPD.pptxjehehejwehdbsenwjjwJohnmvula3
 
Congenital Abnormalities.pptx
Congenital Abnormalities.pptxCongenital Abnormalities.pptx
Congenital Abnormalities.pptxJohnmvula3
 
Unite 3 Congenital Heart Diseases-5.pptx
Unite 3 Congenital Heart Diseases-5.pptxUnite 3 Congenital Heart Diseases-5.pptx
Unite 3 Congenital Heart Diseases-5.pptxJohnmvula3
 
Rheumatoid Arthritis.pptx
Rheumatoid Arthritis.pptxRheumatoid Arthritis.pptx
Rheumatoid Arthritis.pptxJohnmvula3
 
OPHTHALMOLOGY AMT (1).ppt
OPHTHALMOLOGY AMT (1).pptOPHTHALMOLOGY AMT (1).ppt
OPHTHALMOLOGY AMT (1).pptJohnmvula3
 
Seizure Disorders_e4d47f1274c0eb580cc74b0dc2bb3ef9.ppt
Seizure Disorders_e4d47f1274c0eb580cc74b0dc2bb3ef9.pptSeizure Disorders_e4d47f1274c0eb580cc74b0dc2bb3ef9.ppt
Seizure Disorders_e4d47f1274c0eb580cc74b0dc2bb3ef9.pptJohnmvula3
 
Intrauterine fetal death.ppt
Intrauterine fetal death.pptIntrauterine fetal death.ppt
Intrauterine fetal death.pptJohnmvula3
 
EPILEPSY_b182ca5702a81625928c2ca11fe4657d.pdf
EPILEPSY_b182ca5702a81625928c2ca11fe4657d.pdfEPILEPSY_b182ca5702a81625928c2ca11fe4657d.pdf
EPILEPSY_b182ca5702a81625928c2ca11fe4657d.pdfJohnmvula3
 
Glomerulonephritis_2db2d6c17de022051c9782de85d4fdad.pdf
Glomerulonephritis_2db2d6c17de022051c9782de85d4fdad.pdfGlomerulonephritis_2db2d6c17de022051c9782de85d4fdad.pdf
Glomerulonephritis_2db2d6c17de022051c9782de85d4fdad.pdfJohnmvula3
 
Pancreatitis.pptx
Pancreatitis.pptxPancreatitis.pptx
Pancreatitis.pptxJohnmvula3
 
scrotal conditions_d3aa6fe8690749c1a4447f72576e94e2.pdf
scrotal conditions_d3aa6fe8690749c1a4447f72576e94e2.pdfscrotal conditions_d3aa6fe8690749c1a4447f72576e94e2.pdf
scrotal conditions_d3aa6fe8690749c1a4447f72576e94e2.pdfJohnmvula3
 
Major management theorists.KNM (1).pptx
Major management theorists.KNM (1).pptxMajor management theorists.KNM (1).pptx
Major management theorists.KNM (1).pptxJohnmvula3
 
6 Intestinal Obstruction.pptx
6 Intestinal Obstruction.pptx6 Intestinal Obstruction.pptx
6 Intestinal Obstruction.pptxJohnmvula3
 
Introduction to HSM 225.pptx
Introduction to HSM 225.pptxIntroduction to HSM 225.pptx
Introduction to HSM 225.pptxJohnmvula3
 
Cardiovascular drugs 1.ppt
Cardiovascular drugs 1.pptCardiovascular drugs 1.ppt
Cardiovascular drugs 1.pptJohnmvula3
 
Respiratory Distress Syndrome.pdf
Respiratory Distress Syndrome.pdfRespiratory Distress Syndrome.pdf
Respiratory Distress Syndrome.pdfJohnmvula3
 
ANTIHISTAMINES, NASAL DECONGESTANTS AND DRUGS FOR COUGH.pptx
ANTIHISTAMINES, NASAL DECONGESTANTS AND DRUGS FOR COUGH.pptxANTIHISTAMINES, NASAL DECONGESTANTS AND DRUGS FOR COUGH.pptx
ANTIHISTAMINES, NASAL DECONGESTANTS AND DRUGS FOR COUGH.pptxJohnmvula3
 

More from Johnmvula3 (20)

Lecture 30. CRICOTHYROIDOTOMY.pptxzbendj
Lecture 30. CRICOTHYROIDOTOMY.pptxzbendjLecture 30. CRICOTHYROIDOTOMY.pptxzbendj
Lecture 30. CRICOTHYROIDOTOMY.pptxzbendj
 
DISEAShES OF THE EXTERNAL EAR.pdfjdjdjdjdjdjsjssjjssjjsnsns
DISEAShES OF THE EXTERNAL EAR.pdfjdjdjdjdjdjsjssjjssjjsnsnsDISEAShES OF THE EXTERNAL EAR.pdfjdjdjdjdjdjsjssjjssjjsnsns
DISEAShES OF THE EXTERNAL EAR.pdfjdjdjdjdjdjsjssjjssjjsnsns
 
HUMAN IMMUNE DEFICIENCY VIRUS AND AIDS.pptx
HUMAN IMMUNE DEFICIENCY VIRUS AND AIDS.pptxHUMAN IMMUNE DEFICIENCY VIRUS AND AIDS.pptx
HUMAN IMMUNE DEFICIENCY VIRUS AND AIDS.pptx
 
13 - Asthma and COPD.pptxjehehejwehdbsenwjjw
13 - Asthma and COPD.pptxjehehejwehdbsenwjjw13 - Asthma and COPD.pptxjehehejwehdbsenwjjw
13 - Asthma and COPD.pptxjehehejwehdbsenwjjw
 
Congenital Abnormalities.pptx
Congenital Abnormalities.pptxCongenital Abnormalities.pptx
Congenital Abnormalities.pptx
 
Unite 3 Congenital Heart Diseases-5.pptx
Unite 3 Congenital Heart Diseases-5.pptxUnite 3 Congenital Heart Diseases-5.pptx
Unite 3 Congenital Heart Diseases-5.pptx
 
Rheumatoid Arthritis.pptx
Rheumatoid Arthritis.pptxRheumatoid Arthritis.pptx
Rheumatoid Arthritis.pptx
 
OPHTHALMOLOGY AMT (1).ppt
OPHTHALMOLOGY AMT (1).pptOPHTHALMOLOGY AMT (1).ppt
OPHTHALMOLOGY AMT (1).ppt
 
Seizure Disorders_e4d47f1274c0eb580cc74b0dc2bb3ef9.ppt
Seizure Disorders_e4d47f1274c0eb580cc74b0dc2bb3ef9.pptSeizure Disorders_e4d47f1274c0eb580cc74b0dc2bb3ef9.ppt
Seizure Disorders_e4d47f1274c0eb580cc74b0dc2bb3ef9.ppt
 
Intrauterine fetal death.ppt
Intrauterine fetal death.pptIntrauterine fetal death.ppt
Intrauterine fetal death.ppt
 
EPILEPSY_b182ca5702a81625928c2ca11fe4657d.pdf
EPILEPSY_b182ca5702a81625928c2ca11fe4657d.pdfEPILEPSY_b182ca5702a81625928c2ca11fe4657d.pdf
EPILEPSY_b182ca5702a81625928c2ca11fe4657d.pdf
 
Glomerulonephritis_2db2d6c17de022051c9782de85d4fdad.pdf
Glomerulonephritis_2db2d6c17de022051c9782de85d4fdad.pdfGlomerulonephritis_2db2d6c17de022051c9782de85d4fdad.pdf
Glomerulonephritis_2db2d6c17de022051c9782de85d4fdad.pdf
 
Pancreatitis.pptx
Pancreatitis.pptxPancreatitis.pptx
Pancreatitis.pptx
 
scrotal conditions_d3aa6fe8690749c1a4447f72576e94e2.pdf
scrotal conditions_d3aa6fe8690749c1a4447f72576e94e2.pdfscrotal conditions_d3aa6fe8690749c1a4447f72576e94e2.pdf
scrotal conditions_d3aa6fe8690749c1a4447f72576e94e2.pdf
 
Major management theorists.KNM (1).pptx
Major management theorists.KNM (1).pptxMajor management theorists.KNM (1).pptx
Major management theorists.KNM (1).pptx
 
6 Intestinal Obstruction.pptx
6 Intestinal Obstruction.pptx6 Intestinal Obstruction.pptx
6 Intestinal Obstruction.pptx
 
Introduction to HSM 225.pptx
Introduction to HSM 225.pptxIntroduction to HSM 225.pptx
Introduction to HSM 225.pptx
 
Cardiovascular drugs 1.ppt
Cardiovascular drugs 1.pptCardiovascular drugs 1.ppt
Cardiovascular drugs 1.ppt
 
Respiratory Distress Syndrome.pdf
Respiratory Distress Syndrome.pdfRespiratory Distress Syndrome.pdf
Respiratory Distress Syndrome.pdf
 
ANTIHISTAMINES, NASAL DECONGESTANTS AND DRUGS FOR COUGH.pptx
ANTIHISTAMINES, NASAL DECONGESTANTS AND DRUGS FOR COUGH.pptxANTIHISTAMINES, NASAL DECONGESTANTS AND DRUGS FOR COUGH.pptx
ANTIHISTAMINES, NASAL DECONGESTANTS AND DRUGS FOR COUGH.pptx
 

Recently uploaded

Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxNirmalaLoungPoorunde1
 
How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17Celine George
 
Biting mechanism of poisonous snakes.pdf
Biting mechanism of poisonous snakes.pdfBiting mechanism of poisonous snakes.pdf
Biting mechanism of poisonous snakes.pdfadityarao40181
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Educationpboyjonauth
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxmanuelaromero2013
 
Roles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in PharmacovigilanceRoles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in PharmacovigilanceSamikshaHamane
 
Meghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media ComponentMeghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media ComponentInMediaRes1
 
भारत-रोम व्यापार.pptx, Indo-Roman Trade,
भारत-रोम व्यापार.pptx, Indo-Roman Trade,भारत-रोम व्यापार.pptx, Indo-Roman Trade,
भारत-रोम व्यापार.pptx, Indo-Roman Trade,Virag Sontakke
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfSumit Tiwari
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdfssuser54595a
 
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdfFraming an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdfUjwalaBharambe
 
Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatYousafMalik24
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsanshu789521
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptxVS Mahajan Coaching Centre
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTiammrhaywood
 
CELL CYCLE Division Science 8 quarter IV.pptx
CELL CYCLE Division Science 8 quarter IV.pptxCELL CYCLE Division Science 8 quarter IV.pptx
CELL CYCLE Division Science 8 quarter IV.pptxJiesonDelaCerna
 

Recently uploaded (20)

Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptx
 
How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17How to Configure Email Server in Odoo 17
How to Configure Email Server in Odoo 17
 
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
 
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
 
Biting mechanism of poisonous snakes.pdf
Biting mechanism of poisonous snakes.pdfBiting mechanism of poisonous snakes.pdf
Biting mechanism of poisonous snakes.pdf
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Education
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptx
 
Roles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in PharmacovigilanceRoles & Responsibilities in Pharmacovigilance
Roles & Responsibilities in Pharmacovigilance
 
Meghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media ComponentMeghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media Component
 
भारत-रोम व्यापार.pptx, Indo-Roman Trade,
भारत-रोम व्यापार.pptx, Indo-Roman Trade,भारत-रोम व्यापार.pptx, Indo-Roman Trade,
भारत-रोम व्यापार.pptx, Indo-Roman Trade,
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
 
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdfFraming an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
Framing an Appropriate Research Question 6b9b26d93da94caf993c038d9efcdedb.pdf
 
Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice great
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha elections
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
CELL CYCLE Division Science 8 quarter IV.pptx
CELL CYCLE Division Science 8 quarter IV.pptxCELL CYCLE Division Science 8 quarter IV.pptx
CELL CYCLE Division Science 8 quarter IV.pptx
 

Unit 5 Sickle cell-3.pdf

  • 1. Eden University UNIT 5 (Diseases of Blood) Sickle Cell 2,2 Pediatrics Clinical Medicine Dr. D.Nyirongo MD UNZA (BSc.HB, MBChB, DTM)
  • 2. DEFINITIONS • Sickle Cell Anaemia (SCA) is a homozygous Hemoglobinopathy characterized by chronic hemolytic anaemia that results from the inheritance of two mutated β-globin genes coding for hemoglobin S (Hb SS). • Sickle Cell Disease (SCD) A heterozygous Hemoglobinopathy characterized a group of diseases that result from the inheritance of two mutated β-globin genes, one of which is HbS and the other gene is either Hb S or other Hb variants such as Hb C, Hb β-thalassemia, Hb D, and Hb O Arab. • Sickle cell trait (Hb AS) rarely produces disease and this form protects against death from endemic Plasmodium falciparum malaria infection Dr. D. Nyirongo MD 28th July 2023 2
  • 3. Sickle cell • NOTE: In sickle cell Anemia, this change encodes valine instead of glutamine in the 6th position in the β-globin molecule • In sickle cell anemia, Hb S is commonly as high as 90% of the total hemoglobin. • In sickle cell disease, Hb S is >50% of the total hemoglobin. • The mutant gene is inherited in an autosomal recessive manner Dr. D. Nyirongo MD 28th July 2023 3
  • 4. Inheritance of Sickle Cell Anemia • If one parent has sickle cell anaemia (HbSS) and the other is completely unaffected (HbAA) then all the children will have sickle cell trait. • None will have sickle cell anemia. • The parent who has sickle cell anemia (HbSS) can only pass the sickle hemoglobin gene to each of their children. Dr. D. Nyirongo MD 28th July 2023 4
  • 5. Inheritance of Sickle Cell Anemia • If both parents have sickle cell trait (HbAS) there is a one in four (25%) chance that any given child could be born with sickle cell anemia. • There is also a one in four chance that any given child could be completely unaffected. • There is a one in two (50%) chance that any given child will get the sickle cell trait. Dr. D. Nyirongo MD 28th July 2023 5
  • 6. Pathophysiology of anemia in SCA The major pathophysiologic mechanisms in SCA that cause the signs, symptoms and complications are: • Hb S polymerizes in conditions of low oxygen tension leading to distortion of RBC into a crescent ‘sickle’ shape • Sickle RBCs are less deformable and obstruct the microcirculation (vaso-occlusion) resulting in tissue hypoxia • Sickle RBC undergo intravascular and extravascular hemolysis and have a lifespan of only 10-20 days as compared to 120 days of normal RBCs. • There is adhesion of sickle RBCs and leukocytes to activated vascular endothelium leading to vasoconstriction Dr. D. Nyirongo MD 28th July 2023 6
  • 7. Prevalence of symptoms at age • Six month of age - 6% • Twelve months of age - 32% • Two years of age - 61% • Six years of age - 92% • eight years of age - 96% Dr. D. Nyirongo MD 28th July 2023 7
  • 8. CLINICAL FEATURES History of • Swelling and pain of hand and feet i.e. dactylitis (hand and foot syndrome) especially in infancy • Recurrent painful episodes in limbs, abdomen, back, chest • In infancy, may present as unexplained episodes of excessive crying • Recurrent or persistent jaundice • Pallor or anaemia that may require blood transfusions On examination, may have/be • small for age • pallor • Jaundice • frontal and parietal bossing May present in a sickle crises • Vaso-occlusive crisis (has 5 types)  Painful crisis  Dactylitis  Acute chest syndrome  Acute CNS event  Priapism • Hemolytic crisis • Sequestration crisis • Aplastic crisis Dr. D. Nyirongo MD 28th July 2023 8
  • 9. SICKLE CELL CRISES [1] VASO-OCCLUSIVE CRISIS (VOC) • Vaso-occlusive crises occur due to disruption of blood flow in the microvasculature by sickle cells • Resulting in tissue ischemia, temporally loss of function which may become permanent and pain Precipitating Factors for VOC These include:- • Infection, • Dehydration, • Exposure to cold, • Emotional and physical stress, • Hypoxia especially in high altitude Dr. D. Nyirongo MD 28th July 2023 9
  • 10. SICKLE CELL CRISES Vaso-occlusive crises include The following Types i. Painful crisis (most common) ii. Priapism (prolonged, painful erection of the penis) iii. Acute chest syndrome iv. Dactylitis (tender, erythematous and edematous hands and feet) v. Stroke (CVA) and Mnemonic to remember the VOCs= PPADS NOTE: Discuss how each VOC is Managed? (iii) ACUTE CHEST SYNDROME • It is defined a new pulmonary infiltrate on chest radiograph in the presence of one or more of the following: fever, tachypnea, dyspnea, hypoxia and chest pain • In most cases, there is no identifiable cause, but in some cases, it may be caused by Infections – Chlamydia pneumoniae, viral infections, Mycoplasma pneumoniae Pulmonary infarctions (from sickled cells) Fat embolism (from bone marrow infarctions) Dr. D. Nyirongo MD 28th July 2023 10
  • 11. SICKLE CELL CRISES [2] HAEMOLYTIC CRISIS • >2g/dL drop in Hb from baseline with reticulocytosis and raised unconjugated bilirubin • May result due to painful crises or infection • Transfuse with packed cells if Hb fall to <5g/dL [3] SEQUESTRATION CRISIS • It is the sudden enlargement of the spleen along with > 2 g/dL decrease in Hb from baseline with reticulocytosis. • This is an emergency! Because It occurs rapidly and can result in sudden circulatory collapse • It is a common cause of death in infancy Clinical Presentation • Severe pallor with acutely enlarged spleen • Hypovolemic shock • Severe anaemia, thrombocytopenia and normal reticulocyte count Dr. D. Nyirongo MD 28th July 2023 11
  • 12. [4] APLASTIC CRISIS This is a Transient red cell aplasia commonly caused by parvovirus B19 • Parvovirus B19 has a predilection for young erythroblasts in bone marrow which are plentiful in hemolytic anemias • Infection limits the production of reticulocytes • Infection usually is self-limited • May present with fever, upper respiratory tract symptoms, fatigue, pallor. • >2g/dL drop in Hb from baseline, leukopenia with reticulocytopenia. • The reticulocytopenia may last 7 to 10 days Dr. D. Nyirongo MD 28th July 2023 12
  • 13. Long term Complications • Functional asplenia due to autosplenectomy • Increased risk of serious bacterial infections • Faltering growth • Osteomyelitis • CNS conditions • Strokes or TIA, convulsions, sensory hearing loss • Priapism • Delayed sexual maturation • Cholelithiasis • Renal disease (Gross hematuria, papillary necrosis, nephrotic syndrome, renal infarction, hyposthenuria, pyelonephritis, renal medullary carcinoma) • Chronic lung disease (pulmonary hypertension) • Congestive heart failure • Proliferative retinopathy • Leg ulcers • Avascular necrosis of the femoral or humeral heads • Chronic pain syndrome Dr. D. Nyirongo MD 28th July 2023 13
  • 14. Management (Investigations) 1. Clinical 2. Laboratory • FBC • Peripheral Blood Smear reviews Sickle cells, target cells, Howell-jolly bodies • Reticulocyte count • X-ray of the skull (hair on endplate appearance. Frontal bossing) • Sickling test, solubility test and sickle scan All three are screening tests, they do not distinguish between SCD and sickle cell trait and must be followed up by a more specific diagnostic tests eg Hb electrophoresis and HPLC 1. Sickling test – observation of sickled RBCs on a microscope slide when drops of blood are exposed to sodium metabisulphite which causes low oxygen tension 2. Solubility test – observation of turbidity when drops of blood are mixed with sodium dithionate in a test tube, insoluble HbS remains turbid. While HbA which is soluble in the solution turns clear 3. sickle scan- Detects Hb A, C and S (quantitatively) • Hb electrophoresis (measures number, and type of both normal and abnormal Hb) • High-performance liquid chromatography (HPLC) (detects the type of hemoglobin present) Dr. D. Nyirongo MD 28th July 2023 14
  • 15. Management (Treatment) Mainstay treatment  Improve Oxygenation and fluids (1.5 times maintenance fluid)  Pain management (paracetamol->NSAID->Morphine=0.3mg/Kg 4 hourly) NEVER give fentanyl due to risk of seizures  Vaccinate against encapsulated organisms 8 General treatment Principles 1. Folic acid 2. Malaria prophylaxis 3. Antibiotics 4. Avoid crisis precipitants 5. Regular hospital review 6. Counseling 7. Hydroxyurea 8. Blood Transfusion (1) Folic acid 5mg daily (2) Malaria prophylaxis with Deltaprim (pyrimethamine and dapsone) • <12kg 50mg once weekly PO • >12kg, 100mg once weekly PO Side effect: It can cause agranulocytosis (3) Antibiotics (Oral penicillin daily) • because of increased risk of bacterial infections • Penicillin V until the age of 5 years 2 to 12 months 62.5mg BD 1 to 3 years 125mg BD, then 3 to 5 years 250mg BD. If allergic to pen V, give erythromycin. Dr. D. Nyirongo MD 28th July 2023 15
  • 16. Management (Treatment) (4) Avoid crisis precipitants • Precipitants are dehydration, cold, fever, hypoxia • Advice as follows: hydrate enough, keep warm, cool when hot, adequate ventilation • when fever present to go to the clinic/hospital quickly and not self-treat at home (5) Regular hospital review • Frequency of review is based on how patient is doing • Monthly reviews in infancy, 2-3 months in older children or longer if stable (6) Counseling • Teach caregivers and patients about the disease, role of medicines prescribed and how to avoid VOC precipitants • Teach caregivers of SCD children aged <3 years how to palpate for the spleen. After teaching, observe them palpate to ensure they do it correctly • Advise to palpate every day when bathing the child • Advice to go to the hospital (not clinic) quickly if spleen is noted Dr. D. Nyirongo MD 28th July 2023 16
  • 17. Management (Treatment) (7) Hydroxyurea • Mechanisms of action (MOA) Increases the production of fetal Hb (HbF). Decrease red cell endothelial adhesion Increase RBC water content making it flexible and difficult to polymerize Cause Nitric oxide release Vasodilatation Decreases Neutrophil count • o Indicated in stroke, recurrent painful VOC, acute chest syndrome • Dose is 10-15mg/kg once daily initially, then increase every 12 weeks in steps of 2.5-5mg/kg ,max 35mg/kg daily) (8) Blood transfusion This is indicated in:- • Severe anaemia, sequestration crisis, aplastic crisis, acute chest syndrome, priapism, stroke • Do not tansfuse to an Hb to >10g/dL to prevent hyperviscosity which decreases oxygen delivery Give packed cells: transfuse 11 times for 6 Months. 1st Month weekly=4 times 2nd & 3rd Month 2 weekly=4 times Remaining 3 Months Once Monthly=3 times Amount of Blood=(BW x Hb deficiency) x K Where K=4 for packed cells K=6 for whole blood Dr. D. Nyirongo MD 28th July 2023 17
  • 18. Transfusion therapy (Indications) • Vaso-occlusive crisis  Painful crisis  Dactylitis  Acute chest syndrome  CVA (TCD ultrasound results of more than 200cm/s) or stroke  Priapism • Hemolytic crisis • Sequestration crisis • Aplastic crisis • Perioperative NOTE: Do not raise Hb > 10g/dL Transfusion complications • Alloimmunization • Iron overload • Infection Dr. D. Nyirongo MD 28th July 2023 18
  • 19. Causes of death • Infection - 48% • Stroke - 10% • Complications of therapy - 7 % • Splenic sequestration - 7 % • Thromboembolism - 5% • Renal failure - 4 % • Pulmonary hypertension - 3 % Dr. D. Nyirongo MD 28th July 2023 19